Human MOG/BTN6/BTNL11 ORF/cDNA clone-Lentivirus particle (NM_002433)

Cat. No.: vGMLP004771

Pre-made Human MOG/BTN6/BTNL11 Lentiviral expression plasmid for MOG lentivirus packaging, MOG lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Target products collection

Go to MOG/BTN6 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP004771 Human MOG Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP004771
Gene Name MOG
Accession Number NM_002433
Gene ID 4340
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 759 bp
Gene Alias BTN6,BTNL11,MOGIG2,NRCLP7
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCAAGCTTATCAAGACCCTCTCTGCCCAGCTGCCTCTGCTCCTTCCTCCTCCTCCTCCTCCTCCAAGTGTCTTCCAGCTATGCAGGGCAGTTCAGAGTGATAGGACCAAGACACCCTATCCGGGCTCTGGTCGGGGATGAAGTGGAATTGCCATGTCGCATATCTCCTGGGAAGAACGCTACAGGCATGGAGGTGGGGTGGTACCGCCCCCCCTTCTCTAGGGTGGTTCATCTCTACAGAAATGGCAAGGACCAAGATGGAGACCAGGCACCTGAATATCGGGGCCGGACAGAGCTGCTGAAAGATGCTATTGGTGAGGGAAAGGTGACTCTCAGGATCCGGAATGTAAGGTTCTCAGATGAAGGAGGTTTCACCTGCTTCTTCCGAGATCATTCTTACCAAGAGGAGGCAGCAATGGAATTGAAAGTAGAAGATCCTTTCTACTGGGTGAGCCCTGGAGTGCTGGTTCTCCTCGCGGTGCTGCCTGTGCTCCTCCTGCAGATCACTGTTGGCCTCATCTTCCTCTGCCTGCAGTACAGACTGAGAGGAAAACTTCGAGCAGAGATAGAGAATCTCCACCGGACTTTTGATCCCCACTTTCTGAGGGTGCCCTGCTGGAAGATAACCCTGTTTGTAATTGTGCCGGTTCTTGGACCCTTGGTTGCCTTGATCATCTGCTACAACTGGCTACATCGAAGACTAGCAGGGCAATTCCTTGAAGAGCTACTCTTCCACCTGGAAGCCCTCTCTGGCTAA
ORF Protein Sequence MASLSRPSLPSCLCSFLLLLLLQVSSSYAGQFRVIGPRHPIRALVGDEVELPCRISPGKNATGMEVGWYRPPFSRVVHLYRNGKDQDGDQAPEYRGRTELLKDAIGEGKVTLRIRNVRFSDEGGFTCFFRDHSYQEEAAMELKVEDPFYWVSPGVLVLLAVLPVLLLQITVGLIFLCLQYRLRGKLRAEIENLHRTFDPHFLRVPCWKITLFVIVPVLGPLVALIICYNWLHRRLAGQFLEELLFHLEALSG

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T00295-Ab Anti-MOG/ BTN6/ BTNL11IG2 monoclonal antibody
    Target Antigen GM-Tg-g-T00295-Ag MOG VLP (virus-like particle)
    ORF Viral Vector pGMLP004771 Human MOG Lentivirus plasmid
    ORF Viral Vector vGMLP004771 Human MOG Lentivirus particle


    Target information

    Target ID GM-T00295
    Target Name MOG
    Gene Group Identifier
    （Target Gene ID in Homo species)         		4340
    Gene ID 100051908 (Equus caballus), 101099378 (Felis catus), 119867729 (Canis lupus familiaris), 17441 (Mus musculus)
    24558 (Rattus norvegicus), 280863 (Bos taurus), 4340 (Homo sapiens), 711347 (Macaca mulatta)
    Gene Symbols & Synonyms MOG,Mog,B230317G11Rik,BTN6,BTNL11,MOGIG2,NRCLP7
    Target Alternative Names B230317G11Rik,BTN6,BTNL11,MOG,MOGIG2,Mog,Myelin-oligodendrocyte glycoprotein,NRCLP7
    Uniprot Accession P55803,Q16653,Q61885,Q63345
    Additional SwissProt Accessions: Q61885,Q63345,P55803,Q16653
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, Diagnostics Biomarker
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000024468, ENSCAFG00845019151, ENSMUSG00000076439, ENSBTAG00000017818, ENSG00000204655, ENSMMUG00000002967
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.